S Francque Selected Research

S Francque Research Topics

5	Non-alcoholic Fatty Liver Disease 03/2021 - 01/2008
4	Fibrosis (Cirrhosis) 03/2021 - 10/2003
3	Inflammation (Inflammations) 03/2021 - 05/2010
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 03/2021 - 01/2008
2	Liver Failure 12/2017 - 12/2010
2	Hepatocellular Carcinoma (Hepatoma) 03/2012 - 09/2007
2	Insulin Resistance 02/2011 - 05/2010
1	Soft Tissue Infections 07/2022
1	Pancreatitis 07/2022
1	Fatty Liver 03/2021
1	Type 2 Diabetes Mellitus (MODY) 03/2021
1	Infections 07/2018
1	Pericarditis 07/2018
1	Pleural Effusion (Pleural Effusions) 07/2018
1	Chronic Hepatitis B 04/2018
1	Hepatitis B 04/2018
1	Neoplasm Metastasis (Metastasis) 12/2017
1	Hepatitis 12/2017
1	Hepatitis C 01/2016
1	Chronic Hepatitis C 03/2012
1	Liver Diseases (Liver Disease) 03/2012
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2012
1	Morbid Obesity 12/2010
1	Alcoholic Fatty Liver 05/2010
1	Overweight 05/2010
1	Alcoholic Liver Diseases (Alcoholic Liver Disease) 04/2010
1	Neoplasms (Cancer) 01/2010
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2010
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2010
1	Diarrhea 01/2010
1	Short Bowel Syndrome 01/2010
1	Carcinoid Tumor (Carcinoid) 01/2010
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2010
1	Dumping Syndrome (Syndrome, Dumping) 01/2010
1	Obesity 01/2008
1	Hemorrhage 09/2007
1	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 10/2003
1	Necrosis 10/2003

2	N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA 01/2016 - 03/2012
2	telaprevirIBA 01/2016 - 03/2012
2	BilirubinIBA 01/2012 - 10/2003
2	Insulin (Novolin)FDA Link 02/2011 - 01/2008
2	Octreotide (Sandostatin)FDA LinkGeneric 01/2010 - 09/2007
1	SphingolipidsIBA 03/2021
1	Foscarnet FDA LinkGeneric 07/2018
1	DNA (Deoxyribonucleic Acid)IBA 07/2018
1	Ganciclovir (Cytovene)FDA LinkGeneric 07/2018
1	Hepatitis B e AntigensIBA 04/2018
1	Proteins (Proteins, Gene)FDA Link 10/2013
1	Phospholipases (Phospholipase)IBA 10/2013
1	ApolipoproteinsIBA 10/2013
1	RNA (Ribonucleic Acid)IBA 03/2012
1	Protease Inhibitors (Protease Inhibitor)IBA 03/2012
1	InterferonsIBA 03/2012
1	Antiviral Agents (Antivirals)IBA 03/2012
1	Viral ProteinsIBA 03/2012
1	CreatinineIBA 01/2012
1	C-PeptideIBA 02/2011
1	C-Reactive ProteinIBA 05/2010
1	Triglycerides (Triacylglycerol)IBA 05/2010
1	Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA 01/2010
1	LipidsIBA 01/2008
1	Antihypertensive Agents (Antihypertensives)IBA 01/2008
1	Anti-Obesity Agents (Antiobesity Drugs)IBA 01/2008
1	Glucose (Dextrose)FDA LinkGeneric 01/2008
1	Tamoxifen FDA LinkGeneric 09/2007
1	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 10/2003